Seres Therapeutics: 3Q Earnings Snapshot
CAMBRIDGE, Mass. (AP) _ Seres Therapeutics Inc. (MCRB) on Thursday reported a loss of $21.9 million in its third quarter.
The Cambridge, Massachusetts-based company said it had a loss of 54 cents per share.
The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 57 cents per share.
The drug developer posted revenue of $9.1 million in the period.
Seres Therapeutics shares have decreased 20 percent since the beginning of the year. The stock has decreased 16 percent in the last 12 months.